Department of Urology, Stanford University School of Medicine, Stanford, California 94305-5118, USA.
J Biol Chem. 2010 Apr 9;285(15):11465-75. doi: 10.1074/jbc.M109.079327. Epub 2010 Feb 16.
The PIAS proteins (protein inhibitor of activated STAT) were originally identified as inhibitors of the JAK-STAT pathway. Subsequently, their roles on transcriptional regulation have been identified in modulation of the androgen receptor (AR) and other nuclear hormone receptor-mediated actions. Zimp7, also named Zmiz2, is a novel PIAS-like protein and functions as a transcriptional co-activator. In this study, we demonstrate an interaction between Zimp7 and PIAS proteins with higher preference for PIAS3. A modified mammalian one-hybrid assay showed that the NH(2)-terminal proline-rich domain of Zimp7 and the region spanning amino acids 321-486 of PIAS3 were the primary interaction segments. The interaction between Zimp7 and PIAS3 proteins was further confirmed by in vitro protein pull-down and co-immunoprecipitation assays with both exogenous and endogenous proteins. Expression of exogenous PIAS3 further enhances Zimp7-mediated augmentation of AR transcription. Knockdown of the endogenous PIAS3 protein using a specific PIAS3 small hairpin RNA reduced the augmentation of Zimp7 on AR-mediated transcription. Co-localization of Zimp7 and PIAS3 proteins was observed in the nuclei of cells by immunostaining. Exogenous PIAS3 expression enhances the stability of the Zimp7 protein. Using chromatin immunoprecipitation assays, we showed that PIAS3 is involved in the AR- and Zimp7-formed protein complex(es) in the AR downstream target promoter to facilitate androgen-induced transcription. Finally, we further demonstrated that loss of Zimp7 significantly impaired PIAS3-mediated enhancement on AR activity in mouse Zimp7 null (zimp7(-/-)) embryonic fibroblasts. Taken together, these results demonstrate a novel interaction between PIAS and PIAS-like proteins and elucidate a novel regulatory mechanism for PIAS proteins in AR-mediated transcription.
PIAS 蛋白(激活 STAT 的蛋白抑制剂)最初被鉴定为 JAK-STAT 途径的抑制剂。随后,在雄激素受体(AR)和其他核激素受体介导的作用的转录调控中,鉴定了它们在转录调节中的作用。Zimp7,也称为 Zmiz2,是一种新型的 PIAS 样蛋白,作为转录共激活因子发挥作用。在这项研究中,我们证明了 Zimp7 与 PIAS 蛋白之间的相互作用,并且与 PIAS3 的相互作用具有更高的偏好性。改良的哺乳动物单杂交测定表明,Zimp7 的 NH2-末端脯氨酸丰富结构域和 PIAS3 的氨基酸 321-486 跨度区是主要的相互作用片段。体外蛋白下拉和共免疫沉淀实验进一步证实了 Zimp7 和 PIAS3 蛋白之间的相互作用,包括外源性和内源性蛋白。外源性 PIAS3 的表达进一步增强了 Zimp7 介导的 AR 转录的增强作用。使用特定的 PIAS3 短发夹 RNA 敲低内源性 PIAS3 蛋白会降低 Zimp7 对 AR 介导的转录的增强作用。免疫染色显示 Zimp7 和 PIAS3 蛋白在细胞核内共定位。染色质免疫沉淀实验表明,PIAS3 参与 AR 和 Zimp7 形成的蛋白质复合物在 AR 下游靶启动子中,以促进雄激素诱导的转录。最后,我们进一步证明,在缺乏 Zimp7 的情况下,PIAS3 对 AR 活性的增强作用显著受损,在 Zimp7 缺失(zimp7(-/-))的小鼠胚胎成纤维细胞中。总之,这些结果表明了 PIAS 和 PIAS 样蛋白之间的一种新型相互作用,并阐明了 PIAS 蛋白在 AR 介导的转录中的一种新的调节机制。